Prim, S.A. Stock price

Equities

PRM

ES0170884417

Medical Equipment, Supplies & Distribution

Market Closed - BME 12:35:12 2024-03-28 pm EDT 5-day change 1st Jan Change
10.05 EUR 0.00% Intraday chart for Prim, S.A. +0.50% -3.83%
Sales 2023 * 212M 229M Sales 2024 * 228M 246M Capitalization 171M 184M
Net income 2023 * - Net income 2024 * - EV / Sales 2023 * 0.81 x
Net Debt 2023 * 1.02M 1.1M Net cash position 2024 * 9.08M 9.8M EV / Sales 2024 * 0.71 x
P/E ratio 2023 *
12.8 x
P/E ratio 2024 *
8.85 x
Employees 830
Yield 2023 *
3.91%
Yield 2024 *
5.65%
Free-Float 47.28%
More Fundamentals * Assessed data
Dynamic Chart
1 week+0.50%
1 month-1.95%
3 months-4.74%
6 months-5.63%
Current year-3.83%
More quotes
1 week
9.60
Extreme 9.6
10.10
1 month
9.60
Extreme 9.6
10.35
Current year
9.60
Extreme 9.6
10.75
1 year
9.60
Extreme 9.6
12.05
3 years
9.60
Extreme 9.6
15.75
5 years
8.00
Extreme 8
15.75
10 years
5.70
Extreme 5.7
15.75
More quotes
Managers TitleAgeSince
Chief Executive Officer - 20-10-31
Director of Finance/CFO - 17-06-30
Chairman - 19-09-29
Members of the board TitleAgeSince
Director/Board Member 65 15-12-20
Director/Board Member - 18-10-27
- -
More insiders
Date Price Change Volume
24-03-28 10.05 0.00% 4,166
24-03-27 10.05 +0.50% 12,139
24-03-26 10 0.00% 2,153
24-03-25 10 0.00% 3,187
24-03-22 10 +0.20% 4,566

Delayed Quote BME, March 28, 2024 at 12:35 pm EDT

More quotes
Prim SA is a Spain-based company principally engaged in the provision of hospital supplies. The Company's products portfolio comprises implantable orthopedic products, silicone foot products, abduction splints, mastectomy lingerie, prosthetic components, as well as articulated electric beds and various types of accessories for geriatric centers. Through its subsidiary Inmobiliaria Catharsis SA, the Company is also active in the Real State sector. Prim SA is a parent of Grupo Prim, a group which comprises such a number of controlled entities as Enraf Nonius Iberica SA, Establecimientos Ortopedicos Prim SA, and Luga Suministros Medicos SL, among others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.05 EUR
Average target price
16.75 EUR
Spread / Average Target
+66.67%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Prim, S.A. - BME